Prior therapies as prognostic factors of overall survival in metastatic castration-resistant prostate cancer patients treated with [177Lu] Lu-PSMA-617. A WARMTH multicenter study (the 617 trial)

Ahmadzadehfar, Hojjat; Rahbar, Kambiz; Baum, Richard P.; Seifert, Robert; Kessel, Katharina; Bogemann, Martin; Kulkarni, Harshad R.; Zhang, Jingjing; Gerke, Carolin; Fimmers, Rolf; Kratochwil, Clemens; Rathke, Hendrik; Ilhan, Harun; Maffey-Steffan, Johanna; Sathekge, Mike Machaba; Kabasakal, Levent; Osvaldo Garcia-Perez, Francisco; Kairemo, Kalevi; Maharaj, Masha; Paez, Diana; Virgolini, Irene

dc.contributor.author	Ahmadzadehfar, Hojjat
dc.contributor.author	Rahbar, Kambiz
dc.contributor.author	Baum, Richard P.
dc.contributor.author	Seifert, Robert
dc.contributor.author	Kessel, Katharina
dc.contributor.author	Bogemann, Martin
dc.contributor.author	Kulkarni, Harshad R.
dc.contributor.author	Zhang, Jingjing
dc.contributor.author	Gerke, Carolin
dc.contributor.author	Fimmers, Rolf
dc.contributor.author	Kratochwil, Clemens
dc.contributor.author	Rathke, Hendrik
dc.contributor.author	Ilhan, Harun
dc.contributor.author	Maffey-Steffan, Johanna
dc.contributor.author	Sathekge, Mike Machaba
dc.contributor.author	Kabasakal, Levent
dc.contributor.author	Osvaldo Garcia-Perez, Francisco
dc.contributor.author	Kairemo, Kalevi
dc.contributor.author	Maharaj, Masha
dc.contributor.author	Paez, Diana
dc.contributor.author	Virgolini, Irene
dc.date.accessioned	2021-02-15T07:56:50Z
dc.date.available	2021-02-15T07:56:50Z
dc.date.issued	2021-01
dc.description	This article is part of the Topical Collection on Oncology - Genitourinary	en_ZA
dc.description.abstract	Please read abstract in the article.	en_ZA
dc.description.department	Nuclear Medicine	en_ZA
dc.description.librarian	am2021	en_ZA
dc.description.sponsorship	Open Access funding provided by Projekt DEAL.	en_ZA
dc.description.uri	http://link.springer.com/journal/259	en_ZA
dc.identifier.citation	Ahmadzadehfar, H., Rahbar, K., Baum, R.P. et al. Prior therapies as prognostic factors of overall survival in metastatic castration-resistant prostate cancer patients treated with [177Lu]Lu-PSMA-617. A WARMTH multicenter study (the 617 trial) European Journal of Nuclear Medicine and Molecular Imaging, 48, 113–122 (2021). https://doi.org/10.1007/s00259-020-04797-9.	en_ZA
dc.identifier.issn	1619-7070 (print)
dc.identifier.issn	1619-7089 (online)
dc.identifier.other	10.1007/s00259-020-04797-9
dc.identifier.uri	http://hdl.handle.net/2263/78552
dc.language.iso	en	en_ZA
dc.publisher	Springer	en_ZA
dc.rights	© The Author(s) 2020. This article is licensed under a Creative Commons Attribution 4.0 International License.	en_ZA
dc.subject	Radioligand therapy	en_ZA
dc.subject	Lu-PSMA	en_ZA
dc.subject	Chemotherapy	en_ZA
dc.subject	Castration-resistant prostate cancer (CRPC)	en_ZA
dc.subject	Metastatic CRPC (mCRPC)	en_ZA
dc.title	Prior therapies as prognostic factors of overall survival in metastatic castration-resistant prostate cancer patients treated with [177Lu] Lu-PSMA-617. A WARMTH multicenter study (the 617 trial)	en_ZA
dc.type	Article	en_ZA